SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-19-000070
Filing Date
2019-08-26
Accepted
2019-08-26 16:45:39
Documents
5
Period of Report
2019-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-form8xkcfotransition8.htm 8-K 45108
2 EXHIBIT 10.1 sesenbio-monicaforbesemplo.htm EX-10.1 47288
3 EXHIBIT 10.2 sesenbio_formindemnificati.htm EX-10.2 101780
4 EXHIBIT 10.3 cfotransitionpr08262019vf.htm EX-10.3 13006
5 sesenbiomonicaforbese_image1.gif GRAPHIC 6444
  Complete submission text file 0001485003-19-000070.txt   217575
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 191053430
SIC: 2834 Pharmaceutical Preparations